🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.

Several professionals said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Service Response and Material Removal

According to the social media company, the platform has removed problematic material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, populated with images of weight loss, positive reviews and detailed instructions for preparing or administering at residence.

Within moments of entering one group, a seller posted WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, health issues or past usage.

Product Information and Pricing

Within these groups, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant health risks”.